Diet Coke’s decision to launch a slate of new flavors had some critics wondering if the company was heading for another “New Coke” disaster.
But one executive says Coca-Cola has learned from past mistakes.
“We’ve learned that when you have a great thing, you don’t mess with it,” Rafael Acevedo, the company’s North America group director, told Cheddar, pointing out that, unlike with the 1985 marketing fiasco, the classic Diet Coke isn’t going anywhere.
What is changing is the packaging -- the company introduced slimmer cans -- and the flavor options. Ginger Lime, Feisty Cherry, Zesty Blood Orange, and Twisted Mango were added to the line up.
“We’re targeting spice seekers, and we want to target those people who are trying to look for bolder flavors and new experiences,” Acevedo said. “We saw that the sleek can actually connects with the new target as well, it makes the brand feel more premium and more modern. So all the research that we have is telling us that consumers absolutely love it.”
And Diet Coke certainly did its research. The company spent over two years working on this project and talked to about 10,000 consumers to figure out what would work.
For full interview [click here](https://cheddar.com/videos/diet-coke-refreshes-itself-for-2018).
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
